First, the AHA has found no evidence that fish oil supplements have any benefit for warding off cardiovascular disease in healthy people, which includes heart attacks and strokes.

However, the same study concluded that individuals who have had a heart attack or have heart failure are less likely to die if they take 1000 mg of fish oil supplements per day. Taking supplements can reduce the chance of death after heart failure by nine percent.

According to the National Institutes of health, omega-3 fatty acids in fish oil have some benefit in warding off cardiovascular disease. However, many researchers have concluded that the effect is better obtained by eating fish rather than taking supplements. The reason may be that people who include fish in their diets often use the fish as substitution for less heart-healthy food, such as red meat. Individuals who take supplements can still have an unhealthy diet that is too light on fruits and vegetables and too heavy on less healthy food. Seafood also has other healthy nutrients that are absent in fish oil supplements. Many people who eat a lot of fish also pursue other healthy lifestyle choices, such as frequent exercise.

If someone is considering using fish oil supplements as part of a dietary regimen, he or she should consult with a physician before doing so.

Our strategy focuses on enabling our clients to recruit the right people for the structure in which they will perform. Please contact us to learn more about our expertise in Executive Search for Commercial Leadership positions in Medical Device and Biotechnology; including Marketing, Strategy, Sales Leadership, Training, Development, etc. We look forward to the opportunity to help you consistently improve your performance and your business!

1. “Champions aren’t made in gyms. Champions are made from something they have deep inside them-a desire, a dream, a vision. They have to have the skill, and the will. But the will must be stronger than the skill.”

If you were playing sports in the eighties you already know this, made famous by cereals and clothing companies alike. And sure, maybe this is why so many jocks grow up to be Start-Up Executives. In the 2010’s, in contrast, we are buried in mantra’s like “fail fast,” “no risk, no reward,” and “if you aren’t networking, you aren’t working,” but these are platitudes. Things somebody said once, and so they kept getting said. Independent of empirical evidence. Know what is empirically evident? Skills get you hired and they might even get you funded. And yet: will gets you to the top―here I am talking about pretty much every mountain ever.

2. “Friendship is the hardest thing in the world to explain. It’s not something you learn in school. But if you haven’t learned the meaning of friendship, you really haven’t learned anything.”

Back to the “if you aren’t networking, you aren’t working” platitude I just referenced. If you aren’t using metrics to determine the true cost-benefit relationship of your networking, you may not be totally getting it. And that’s because you are still misunderstanding friendship (yeah, as Muhammad just said, “you really haven’t learned anything”). Over-investing in visibility is common and can be a costly mistake today. Remember when you were 18 and finally figured out it was quality not quantity that rendered friendships useful? Still true.

3. “What you’re thinking is what you’re becoming.”

In business when you aren’t thinking, you aren’t becoming. Further, if you aren’t communicating what you are thinking, in a manner that is effective and efficient, well … you could be inhibiting your becoming. Can’t explain your business on an elevator ride to the fourth floor? Then your communicating is outdated. Try filling out the Lean Canvas template (ask Google) if you want to get lean at explaining yourself and your potential.

4. “I’m a fighter. I believe in the eye-for-an-eye business. I’m no cheek turner. I got no respect for a man who won’t hit back. You kill my dog, you better hide your cat.”

Okay, this one made the list because sometimes I like controversy. You can reword this as “sting like a bee” if you are bothered. The point is capitalism is a pro-growth business, not a shrink and take it business. Sure, capital begets capital, but you’re old enough to know by now that you’ve got to hit back. And I’m taking at the micro and macro levels, alike.

5. “It’s not bragging if you can back it up.”

This one is here because, duh. In business as in life, we are always better off if invested in backing it up.

Bonus: “Silence is golden when you can’t think of a good answer.”

Can we start a cultural movement around this last? Let’s imagine, together and for just a moment, a world in which this is a shared understanding. We’ve all been in board/executive meetings…. You just sighed longingly didn’t you?

One of the shocking reveals in the second to last episode of “Mad Men,” the long running series about 1960s-era advertising men and the women who love them, concerned Betty Draper Francis’ diagnosis of terminal lung cancer, which had spread to the bones. The diagnosis could have been expected for the character, depicted in the series as a chain smoker.

Health Magazine consulted with some modern doctors about Betty’s situation. The sad news is that Betty has about six to seven months to live, given how oncology was practiced in 1970. The even sadder news is that her likely lifespan would only be a year if she had gotten the same diagnosis in 2015. To be sure, certain chemotherapies exist in 2015 that were not available in 1970. Oral therapies that target certain types of lung cancer and may expand the lifespan of the patient considerably are also available.

The good news is that upcoming advances in immunotherapy have the potential to positively affect the survival rates of lung cancer patients. The idea is to use the body’s immune system to combat the cancer, searching out and destroying the tumors. This kind of therapy will likely be effective in ensuring that the cancer does not recur after going into remission.

One scene in the episode has proven infuriating to modern audiences. It occurs when the doctor describes to Betty’s husband what is in store for her in a cold, clinical way as Betty listens with no doubt mounting horror. This kind of consultation, where a wife was involved, was standard practice in medicine of the time but is no longer the case in the modern era.

Biotech has been in practice to some degree for thousands of years, from ancient agriculture to early brewing, spanning centuries in between. The industry itself began merely decades ago, but technological advances have provided opportunities for our societies to grow, and the study and implementation of biotechnology is no exception. Public and private companies continue to support the research and advancement of biotech tools and products for food, medicine, and more.

Pharmacogenomics is a newer field of study in biotechnology and pharmacology, which “seeks to determine how a patient’s genetic profile affects his/her responses to particular medicines,” according to Amgen, a leader of biotech research. This will lead to a better understanding of the effects of test drugs in patients, based on genetic factors and abnormalities.

Relatedly, biomedicine is growing in leaps and bounds. Biologic medicines for over 250 diseases and 300 cancer-related conditions are currently in production reports the Biotechnology Industry Organization. More than 200 biomedicines have already been approved in recent years, and the industry continues to research treatments for terrible issues like cancer, Alzheimer’s, and AIDS.

Following national trends towards sustainable development, biotechnological research through BIO and other organizations is being used “to slow the use of nonrenewable resources, such as oil and mineral ores, to allow time for substitutes to be found and to avoid using renewable resources, such as water, soil and trees, faster than they are replenished.” The use of biofuels and agricultural biotech are aimed at working towards a more self-sustaining society through science.

In what many might consider a page from a science fiction novel, DARPA’s Biological Technologies Office is claiming research towards artificial intelligence, robotic aircrafts, and more “programs [that] operate across a wide range of scales, from individual cells to complex biological systems including mammalian and non-mammalian organisms and the macro- and micro-environments in which they operate.”

Biotechnology is leading the future across all fields of humanity. Keep up to date with the newest innovations and advancing applications and the experts in the fields. The future is within our reach.

Company Profile

"Prime-Core, Inc is an Executive Search Firm that is passionate about helping med tech companies meet their Human Capital needs in order to foster a team dedicated to success.
We believe there is a story behind every successful hire. One that stands the tests of time and truly transforms a good company to great company."